Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Sanofi
SNY
|
$1.44B |
| 2 |
ConocoPhillips
COP
|
$1.27B |
| 3 |
Fiserv
FI
|
$958M |
| 4 |
GSK
GSK
|
$893M |
| 5 |
Alibaba
BABA
|
$629M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$1.67B |
| 2 |
Bank of America
BAC
|
$1.16B |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
$1.05B |
| 4 |
Capital One
COF
|
$960M |
| 5 |
HP
HPQ
|
$775M |
Sector Composition
| 1 | Financials | 26.36% |
| 2 | Technology | 18.58% |
| 3 | Healthcare | 14.71% |
| 4 | Communication Services | 14.08% |
| 5 | Energy | 9.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Caterpillar
CAT
$196B
| $9.18M | 0.01% |
39,602
-1,338
| -3% | -$310K |
|
102
PayPal
PYPL
$67.1B
| $8.66M | 0.01% |
35,650
-800
| -2% | -$194K |
|
|
MXIM
103
DELISTED
Maxim Integrated Products
MXIM
| $7.4M | 0.01% |
80,975
-4,283
| -5% | -$391K |
|
104
Corning
GLW
$57.4B
| $7.25M | 0.01% |
166,602
-5,450
| -3% | -$237K |
|
105
IBM
IBM
$227B
| $6.52M | ﹤0.01% |
48,939
-3,571
| -7% | -$476K |
|
106
Exxon Mobil
XOM
$487B
| $6.32M | ﹤0.01% |
113,264
+763
| +0.7% | +$42.6K |
|
107
Pfizer
PFE
$141B
| $6.1M | ﹤0.01% |
168,379
-29,027
| -15% | -$1.05M |
|
108
Vulcan Materials
VMC
$38.5B
| $5.83M | ﹤0.01% |
34,550
-1,150
| -3% | -$194K |
|
109
Deere & Co
DE
$129B
| $5.21M | ﹤0.01% |
13,914
-1,565
| -10% | -$586K |
|
110
Boston Scientific
BSX
$156B
| $5.07M | ﹤0.01% |
131,290
-1,700
| -1% | -$65.7K |
|
111
Apple
AAPL
$3.45T
| $5.03M | ﹤0.01% |
41,156
| – | – |
|
112
Amgen
AMGN
$155B
| $4.43M | ﹤0.01% |
17,787
-70
| -0.4% | -$17.4K |
|
113
Johnson & Johnson
JNJ
$427B
| $4.28M | ﹤0.01% |
26,056
+1
| +0% | +$164 |
|
114
GE Aerospace
GE
$292B
| $4.16M | ﹤0.01% |
317,083
-362,100
| -53% | -$4.75M |
|
115
Danaher
DHR
$147B
| $4.09M | ﹤0.01% |
18,167
-500
| -3% | -$113K |
|
116
US Bancorp
USB
$76B
| $3.77M | ﹤0.01% |
68,189
-14,311
| -17% | -$792K |
|
117
Synopsys
SNPS
$112B
| $3.63M | ﹤0.01% |
14,630
-700
| -5% | -$173K |
|
118
DuPont de Nemours
DD
$32.2B
| $3.49M | ﹤0.01% |
45,169
-1,656
| -4% | -$128K |
|
119
Berkshire Hathaway Class B
BRK.B
$1.09T
| $3.28M | ﹤0.01% |
12,820
| – | – |
|
|
RDS.A
120
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $3.08M | ﹤0.01% |
78,598
-3,433
| -4% | -$135K |
|
121
McDonald's
MCD
$224B
| $2.88M | ﹤0.01% |
12,825
-850
| -6% | -$191K |
|
122
eBay
EBAY
$41.4B
| $2.84M | ﹤0.01% |
46,381
-800
| -2% | -$49K |
|
123
Diageo
DEO
$62.1B
| $2.76M | ﹤0.01% |
16,811
| – | – |
|
124
3M
MMM
$82.8B
| $2.69M | ﹤0.01% |
13,955
-200
| -1% | -$38.5K |
|
125
Unilever
UL
$155B
| $2.65M | ﹤0.01% |
47,471
-1,267
| -3% | -$70.7K |
|